Purpose Intrahepatic cholangiocarcinoma (ICC) has a poor prognosis, when unresectable;
therefore, intra-arterial therapies (IAT) such as trans-arterial chemoembolization (TACE) and …

To this date, it is a major oncological challenge to optimally diagnose, stage, and manage
intrahepatic cholangiocarcinoma (ICC). Imaging can not only diagnose and stage ICC, but it …

Objectives To investigate associations between apparent diffusion coefficient (ADC) and cell
count, Ki 67, tumor-stroma ratio (TSR), and tumoral lymphocytes in different hepatic …

Purpose To report outcomes of yttrium-90 (90 Y) radioembolization in patients with
unresectable intrahepatic cholangiocarcinoma (ICC). Materials and Methods Retrospective …

Purpose To determine the safety and effectiveness of yttrium-90 transarterial
radioembolization (TARE) combined with systemic gemcitabine, cisplatin, and capecitabine …

Intrahepatic cholangiocarcinoma (ICC) is an aggressive biliary tract cancer (BTC) that arises
from the biliary tract epithelium distal to the secondary biliary radicals. Over the past decade …

Objectives To construct a preoperative model for survival prediction in intrahepatic
cholangiocarcinoma (ICC) patients using ultrasound (US) based radiographic‐radiomics …

Background Most intrahepatic cholangiocarcinomas (ICCs) are diagnosed at advanced
stage with an extremely poor prognosis. For these patients, combining targeted therapies …

Purpose To evaluate whether baseline MRI can help predict survival in patients with
unresectable intrahepatic cholangiocarcinoma (ICCA) undergoing transcatheter arterial …

Introduction Intrahepatic cholangiocarcinoma is the second most common liver cancer.
Desmoplastic stroma may be revealed as distinctive histopathologic findings favoring …